
Please try another search
By Nupur Anand
MUMBAI (Reuters) - India's Paytm Payments Bank, which facilitates transactions on mobile commerce platform Paytm, expects the central bank to allow it to resume taking on new customers in the next few months, a top executive told Reuters.
In March, the Reserve Bank of India ordered a comprehensive audit of the company's IT systems, citing "material" supervisory concerns, without elaborating further, and barring it from taking on new customers.
The bank is working with the RBI to complete the IT audit and address the regulator's concerns.
"The process is underway and we think it should take three to five months from where we are right now," Madhur Deora, group chief financial officer, Paytm, told Reuters on Sunday.
The central bank did not immediately respond to an email seeking comments.
Paytm in March denied a Bloomberg news report that said RBI had found its servers were sharing information with China-based entities that indirectly own a stake in the firm.
Paytm is backed by China's Alibaba (NYSE:BABA) Group Holding and its affiliate Ant Group.
One 97 Communications Ltd, the parent of fintech firm Paytm, on Friday reported a wider fourth-quarter loss due to higher payment processing, marketing and employee costs.
Deora said the company was on track to achieve profitability by September 2023.
"We are seeing good growth in high margin businesses and as a result we are seeing improvements in contribution margin."
"Our indirect expenses will not grow as fast as last year as we don't expect to make any significant investments in new businesses or employee cost this year as we have already made those in the last year," he added.
Paytm made its stock market debut in November last year in one of the country's biggest-ever initial public offerings, but the shares have since sunk 70%.
By Yasin Ebrahim Investing.com -- The S&P 500 jumped Wednesday, powered by tech as the Federal Reserve's June meeting minutes reaffirmed the central bank's commitment to stop...
By Pete Schroeder WASHINGTON (Reuters) - Wall Street held steady while oil slid on Wednesday as investors juggled concerns over inflation versus a recession, after Federal Reserve...
By Manas Mishra and Michael Erman (Reuters) -The U.S. Food and Drug Administration said on Wednesday it authorized state-licensed pharmacists to prescribe Pfizer Inc...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.